Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
Total Valuation
REPRO-MED Systems has a market cap or net worth of $122.74M. The enterprise value is ―.
Market Cap$122.74M
Enterprise Value―
Share Statistics
REPRO-MED Systems has 46,140,995 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,140,995
Owned by Insiders17.30%
Owned by Institutions24.97%
Financial Efficiency
REPRO-MED Systems’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -27.06%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-27.06%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee420.58K
Profits Per Employee-75.83K
Employee Count80
Asset Turnover1.24
Inventory Turnover4.39
Valuation Ratios
The current PE Ratio of REPRO-MED Systems is -29.07. REPRO-MED Systems’s PEG ratio is -0.31.
PE Ratio-29.07
PS Ratio0.00
PB Ratio6.92
Price to Fair Value10.49
Price to FCF-72.12
Price to Operating Cash Flow-363.88
PEG Ratio-0.31
Income Statement
In the last 12 months, REPRO-MED Systems had revenue of 33.65M and earned -6.07M in profits. Earnings per share was -0.13.
Revenue33.65M
Gross Profit21.33M
Operating Income-5.56M
Pretax Income-6.07M
Net Income-6.07M
EBITDA-5.56M
Earnings Per Share (EPS)-0.13
Cash Flow
In the last 12 months, operating cash flow was -319.72K and capital expenditures -1.30M, giving a free cash flow of -1.62M billion.
Operating Cash Flow-319.72K
Free Cash Flow-1.62M
Free Cash Flow per Share-0.04
Dividends & Yields
REPRO-MED Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.72
52-Week Price Change25.47%
50-Day Moving Average2.67
200-Day Moving Average3.12
Relative Strength Index (RSI)43.51
Average Volume (3m)119.28K
Important Dates
REPRO-MED Systems upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
REPRO-MED Systems as a current ratio of 2.66, with Debt / Equity ratio of 22.12%
Current Ratio2.66
Quick Ratio2.27
Debt to Market Cap0.02
Net Debt to EBITDA1.05
Interest Coverage Ratio0.00
Taxes
In the past 12 months, REPRO-MED Systems has paid -2.89K in taxes.
Income Tax-2.89K
Effective Tax Rate<0.01
Enterprise Valuation
REPRO-MED Systems EV to EBITDA ratio is -30.67, with an EV/FCF ratio of -105.42.
EV to Sales5.07
EV to EBITDA-30.67
EV to Free Cash Flow-105.42
EV to Operating Cash Flow-533.21
Balance Sheet
REPRO-MED Systems has $9.58M in cash and marketable securities with $3.72M in debt, giving a net cash position of -$5.86M billion.
Cash & Marketable Securities$9.58M
Total Debt$3.72M
Net Cash-$5.86M
Net Cash Per Share-$0.13
Tangible Book Value Per Share$0.35
Margins
Gross margin is 62.71%, with operating margin of -16.52%, and net profit margin of -18.03%.
Gross Margin62.71%
Operating Margin-16.52%
Pretax Margin-18.04%
Net Profit Margin-18.03%
EBITDA Margin-16.52%
EBIT Margin-19.16%
Analyst Forecast
The average price target for REPRO-MED Systems is $4.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$4.83
Price Target Upside81.58% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast19.65%
EPS Growth Forecast60.28%